Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Article numbere0164862
JournalPLOS ONE
Volume11
Issue number11
DOIs
Publication statusPublished - 3 Nov 2016

Cite this